Open innovation : a real option to restore value to the biopharmaceutical R&D
Year of publication: |
2014
|
---|---|
Authors: | Lo Nigro, Giovanna ; Morreale, Azzurra ; Enea, Gianluca |
Published in: |
International journal of production economics. - Amsterdam [u.a.] : Elsevier, ISSN 0925-5273, ZDB-ID 1092526-0. - Vol. 149.2014, p. 183-193
|
Subject: | Real options analysis | Licensing | Open innovation | Biopharmaceutical industry | R&D portfolio | Realoptionsansatz | Innovationsmanagement | Innovation management | Pharmaindustrie | Pharmaceutical industry | Lizenz | Licence | Open Innovation | Biotechnologie-Industrie | Biotechnology industry | Investitionsentscheidung | Investment decision | Pharmakologie | Pharmacology |
-
How can small firms benefit from open innovation? : the case of new drug development in Taiwan
Su, Yu-Shan, (2016)
-
Development of innovation cooperation in the time of COVID-19 pandemic
Puślecki, Łukasz, (2021)
-
Mazzola, Erica, (2016)
- More ...
-
Open innovation: A real option to restore value to the biopharmaceutical R&D
Lo Nigro, Giovanna, (2014)
-
Biopharmaceutical alliances and competition : a real options games approach
Lo Nigro, Giovanna, (2013)
-
Uncertain outcome presentations bias decisions : experimental evidence from Finland and Italy
Morreale, Azzurra, (2018)
- More ...